Sign in

CIK 0001790340 · <br>Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 43 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-14 Feinberg Peter Director Grant or award · Stock Option +17,500 17,500
2023-06-14 CARPENTER ROBERT J Director Grant or award · Stock Option +17,500 17,500
2023-06-14 BERMAN ANN E Director Grant or award · Stock Option +17,500 17,500
2023-06-13 Morales Mallory VICE PRESIDENT, FINANCE Grant or award · Stock Option +15,000 15,000
2023-03-31 Brakewood Harold Eugene Chief Business Officer Grant or award · Stock Option +165,000 165,000
2023-02-15 Morales Mallory VICE PRESIDENT, FINANCE Grant or award · Stock Option +72,000 72,000
2023-02-15 Neufeld Leah R CHIEF PEOPLE OFFICER Grant or award · Stock Option +105,000 105,000
2023-02-15 Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Grant or award · Stock Option +187,000 187,000
2023-02-15 Zeskind Benjamin J. PRESIDENT AND CEO Grant or award · Stock Option +352,244 352,244
2023-02-15 Zeskind Benjamin J. PRESIDENT AND CEO Grant or award · Stock Option +21,756 374,000

Page 8 of 8 · 150 trades